Showing 41 - 60 results of 485 for search '(( significantly ((we decrease) OR (a decrease)) ) OR ( significantly mean decrease ))~', query time: 0.48s Refine Results
  1. 41

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  2. 42
  3. 43

    Characteristics of the included studies. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  4. 44

    Summary of results. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  5. 45

    Bias risk assessments for each RCT study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  6. 46

    The flow chart of studies selecting. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  7. 47

    Funnel plots for intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  8. 48

    Bias risk assessments for each RCS study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  9. 49

    Characteristics of JIA patients. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Twelve studies published between 2003 and 2018 were analyzed, encompassing 1513 patients with a mean age of 11.4 years. Tumor necrosis factor alpha inhibitors were the predominant biologic agents used (75.8%), with a mean follow-up duration of 2 years post-biologic therapy initiation. …”
  10. 50

    List of excluded articles. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Twelve studies published between 2003 and 2018 were analyzed, encompassing 1513 patients with a mean age of 11.4 years. Tumor necrosis factor alpha inhibitors were the predominant biologic agents used (75.8%), with a mean follow-up duration of 2 years post-biologic therapy initiation. …”
  11. 51
  12. 52

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …”
  13. 53

    Clinical characteristics. by Clemens Plattner (21567706)

    Published 2025
    “…Survival curves were estimated using the Kaplan-Meier plot and compared using the Log-rank test.</p><p>Results</p><p>Mean age at T2D diagnosis was significantly lower in the FHD group, while time to insulin initiation was independent from FHD status. …”
  14. 54

    Demographics of the enrolled patients. by Yuka Kasai (21354922)

    Published 2025
    “…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”
  15. 55

    Overhead view of the eye drop aid. by Yuka Kasai (21354922)

    Published 2025
    “…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”
  16. 56

    Summary statistics of key variables. by Saul Estrin (8629173)

    Published 2024
    “…We find that in developing countries, as urban economic density increases, innovation first increases and then begins to decrease beyond a certain point, with the decline being most prominent in the largest cities. …”
  17. 57

    Characteristics of the included studies. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  18. 58

    Extracted data and used for analysis. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  19. 59

    Excluded studies with reasons for exclusion. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  20. 60

    Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    “…Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”